The human trisomy 21 brain: Insights from mouse models of Down syndrome

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 2, Issue 2, 1996, Pages 66-72

  Holtzman, David M ^a   Epstein, Charles J ^b   Mobley, William C ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Down syndrome; Trisomy 16; Trisomy 21

Indexed keywords

EID: 0002906659     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2779(1996)2:2<66::aid-mrdd2>3.3.co;2-g     Document Type: Article

References (28)

1. Ault B, Caviedes P, Rapoport SI (1989): Neurophysiological abnormalities in cultured dorsal root ganglion neurons from the trisomy 16 mouse fetus, a model for Down syndrome. Brain Res 485:165-170.
2. Bellugi U, Wang PP, Jernigan TL (1994): Atypical Cognitive Deficits in Developmental Disor-ders: Implications for Brain Function. Hillsdale, NJ: Lawrence Erlbaum Associates.
3. Casanova MF, Walker LC, Whitehouse PJ et al. (1985): Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18:310-313.
4. Colton CA, Yao J, Gilbert D et al. (1990): Enhanced production of superoxide anion by microglia from trisomy 16 mice. Brain Res 519:236-242.
5. Corsi P, Coyle JT (1991): Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse. Proc Natl Acad Sci USA 88:1793-1797.
6. Cox DR, Epstein LB, Epstein CJ (1980): Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. Proc Natl Acad Sci USA 77:2168-2172.
7. Cox DR, Smith SA, Epstein LB et al. (1984): Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): Production of viable trisomy 16 ↔ diploid mouse chimeras. Dev Biol 101:416-424.
8. Coyle JT, Oster-Granite ML, Reeves RH et al. (1988): Down syndrome, Alzheimer's disease, and the trisomy 16 mouse. Trends Neurosci 11:390-394.
9. Davisson MT, Schmidt C, Reeves RH et al. (1993): Segmental trisomy as a mouse model for Down syndrome. In Epstein CJ (ed): The Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions. New York: John Wiley & Sons, pp 117-133.
10. Epstein CJ (1986): Consequences of Chromosome Imbalance: Principals, Mechanisms, and Models. New York: Cambridge University Press.
11. Epstein CJ, Foster DB, DeArmond SJ et al. (1991): Accleration of scrapie in trisomy 16 ↔ diploid aggregation chimeras. Ann Neurol 29:95-97.
12. Escorihuela RM, Fernandez-Teruel A, Vallina IF et al. (1995): A behavioral assessment of Ts65DN mice, a putative Down syndrome model. Neurosci Lett 199:143-146.
13. Fine A, Ault B, Rapoport SI (1991): Mouse trisomy 16 neurons, a model of human trisomy 21 (Down syndrome), can be maintained by intracerebral transplantation. Neurosci Lett 122:4.
14. Galdzicki Z, Coan E, Rapoport SI (1993): Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current. Brain Res 604:69-78.
15. Games D, Adams D, Alessandrini R et al. (1995): Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
16. Gearhart JD, Davisson MT, Oster-Granite ML (1986): Autosomal aneuploidy in mice: Generation and developmental consequences. Brain Res Bull 16:789-801.
17. Goate A, Chartier-Harlon MC, Mullan M et al. (1991): Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
18. Golden JA, Hyman BT (1994): Development of the superior temporal neocortex is anomalous in trisomy 21. J Neuropathol Exp Neurol 53:513-520.
19. Griffin WST, Stanley LC, Ling C et al. (1989): Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
20. Gropp A, Kolbus U, Giers D (1975): Systematic approach to the study of trisomy in the mouse II. Cytogenet Cell Genet 14:42-62.
21. Hayes A, Datshaw ML (1994): Down syndrome. Pediatr Clin North Am 40:523-529.
22. Higgins LS, Holtzman DM, Rabin J et al. (1994): Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 35:598-607.
23. Holtzman DM, Bayney RM, Li Y et al. (1992a): Dysregularion of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J 11:619-627.
24. Holtzman DM, Kilbridge J, Chen KS et al. (1995): Preliminary characterization of the nervous system in partial trisomy 16 mice. In Epstein CJ (ed): Etiology and Pathogenesis of Down Syndrome. New York: John Wiley & Sons, pp 227-240.
25. Holtzman DM, Li Y, Chen K et al. (1993): Nerve growth factor reverses neuronal atrophy in a Down syndrome model of neurodegeneration. Neurology 43:2668-2673.
26. Holtzman DM, Li Y, DeAnnond SJ et al. (1992b): A mouse model of neurodegeneration: Atrophy of basal forebrain neurons in Ts 16 transplants. Proc Natl Acad Sci USA 89:1383-1387.
27. Holtzman DM, Mobley WC (1991): Molecular studies in Alzheimer's disease. Trends Biochem Sci 16:140-144.
28. lonasescu W (1995): Charcot-Marie-Tooth neuropathies: From clinical description to molecular genetics. Muscle Nerve 18:267-275.